Smallpox Vaccine Manufacturers See Big Stock Price Increases After Monkeypox Outbreaks Reported
On May 26, 2022, U.S. Centers for Disease Control (CDC) officials held a press briefing and announced there had been nine cases of monkeypox identified in seven U.S. states and that two licensed smallpox vaccines were in the national stockpile and ready to be distributed.1 The CDC’s director said, “The U.S. has the resources we […]
Moderna CEO Was Paid $18.2 Million in 2021
As COVID-19 vaccine sales continue to soar, Moderna Chief Executive Stephane Bancel’s total personal financial compensation increased by 41 percent in 2021, reaching $18.2 million. The company’s total revenue rose 2,200 percent in 2021, jumping from $803 million to $18.5 billion.1 2 Moderna partnered with the National Institute of Allergy and Infectious Diseases (NIAID), headed […]
Physicians See Increased Medical Errors Due to Staff Shortages
Survey Healthcare Global, a subsidiary of Apollo Intelligence, a data collection service for health care market research, released a new report showing that 34 percent of physicians in six developed countries said they have observed an increase in medical errors as a result of staff shortages.1 Shortage of Health Care Professionals Affecting Physicians’ Mental Health […]
Pfizer CEO Received $24.3 Million in Total Compensation for 2021
Pfizer CEO Albert Bourla, who recently announced that a fourth COVID-19 vaccine dose will be necessary for everyone who has already gotten three doses, was awarded $24.3 million in personal financial compensation in 2021. In addition to his $1.69 million salary, which increased by 15 percent, Bourla took home a cash incentive of $8 million, […]
U.S. Consumers Warned About Fraudulent Coronavirus Testing Sites
The U.S. Department of Health and Human Services Office of Inspector General has issued a warning to the public about fraudulent schemes and scams related to COVID-19 services and testing that involve telemarketing calls, text messages, social media platforms, and door-to-door visits.1 At the outset of the SARS-CoV-2 pandemic, there was a proliferation of fraudulent […]
Pfizer Withdraws EUA Application for COVID Shot in India After Regulator Asks for Independent Safety Study
Pfizer, Inc. has withdrawn its emergency use authorization (EUA) application for its experimental BNT162b2 (also known as “Comirnaty”) messenger RNA (mRNA) COVID-19 biologic (developed in collaboration with Germany’s BioNTech) in India.1 Pfizer was the first pharmaceutical company to apply for an EUA to distribute a COVID biologic in India in 2021. However, India’s regulatory agency […]
